↓ Skip to main content

Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses

Overview of attention for article published in Leukemia & Lymphoma, March 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses
Published in
Leukemia & Lymphoma, March 2019
DOI 10.1080/10428194.2019.1576871
Pubmed ID
Authors

Justin R. Arnall, Donald C. Moore, Hailey L. Hill, Sarah Griffin, Maxine K. Mueller, Lesli A. Lavery, Peter M. Voorhees, Saad Z. Usmani

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 33%
Professor 2 22%
Student > Bachelor 1 11%
Other 1 11%
Unknown 2 22%
Readers by discipline Count As %
Medicine and Dentistry 4 44%
Biochemistry, Genetics and Molecular Biology 1 11%
Arts and Humanities 1 11%
Unknown 3 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2020.
All research outputs
#18,698,279
of 23,173,635 outputs
Outputs from Leukemia & Lymphoma
#2,875
of 4,029 outputs
Outputs of similar age
#266,576
of 351,841 outputs
Outputs of similar age from Leukemia & Lymphoma
#33
of 97 outputs
Altmetric has tracked 23,173,635 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,029 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,841 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.